5-氯-3-乙基苯并恶唑-2(3H)-酮 | 5790-91-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并恶唑类
• 中文名称: 5-氯-3-乙基苯并恶唑-2(3H)-酮
• 英文名称: 5-chloro-3-ethylbenzo[d]oxazol-2(3H)-one
• 英文别名: 5-chloro-3-ethyl-3H-benzooxazol-2-one；3-Ethyl-5-chlorobenzoxazolone；5-Chlor-2-oxo-3-aethyl-2.3-dihydro-benzoxazol；2-Benzoxazolinone, 5-chloro-3-ethyl-；5-chloro-3-ethyl-1,3-benzoxazol-2-one
• CAS: 5790-91-0
• 化学式: C₉H₈ClNO₂
• 分子量: 197.621
• InChiKey: NGNSUTIRTDXXGA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  碘乙烷 、 氯唑沙宗 反应 2.0h， 以98%的产率得到5-氯-3-乙基苯并恶唑-2(3H)-酮
  参考文献：
  名称：

  Electrogenerated N-heterocyclic carbenes: N-functionalization of benzoxazolones

  摘要：

  A simple electrochemical procedure for the N-acylation and N-alkylation of benzoxazol-2(3H)-ones has been set up via electrolysis of an ionic liquid containing a benzoxazolone followed by addition of saturated or unsaturated anhydrides or alkyl halides. The electrochemically induced N-functionalization of benzoxazol-2(3H)-ones works very well in all tested ionic liquids, avoiding the use of volatile organic solvents. The N-acyl and N-alkyl derivatives of benzoxazol-2(3H)-ones were isolated in good to excellent yields; moreover, the ionic liquid has been reused fivefold maintaining the high yield of the products. (C) 2009 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2009.02.057

文献信息

• Benzimidazolone-, benzoxazolone-, or benzothiazolone derivatives as ion channel modulating agents
  申请人：——

  公开号：US20020055526A1

  公开（公告）日：2002-05-09

  The present invention relates to ion channel modulating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as modulators of SK Ca , IK Ca and BK Ca channels. In further aspects, the present invention relates to the use of these SK/IK/BK channel modulating agents for the manufacture of medicaments, and pharmaceutical compositions comprising the SK/IK/BK channel modulating agents. The SK/IK/BK channel modulating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK/BK channels.

  本发明涉及离子通道调节剂。更具体地，本发明涉及一类特定的化合物，已被证明可作为SKCa、IKCa和BKCa通道的调节剂。此外，本发明还涉及利用这些SK/IK/BK通道调节剂制造药物，并包括这些SK/IK/BK通道调节剂的药物组合物。本发明的SK/IK/BK通道调节剂可用于治疗或缓解与SK/IK/BK通道相关的疾病和症状。
• [EN] NEW BENZIMIDAZOLONE-, BENZOXAZOLONE-, OR BENZOTHIAZOLONE DERIVATIVES AS ION CHANNEL MODULATING AGENTS<br/>[FR] NOUVEAUX DERIVES DE BENZIMIDAZOLONE, DE BENZOXAZOLONE OU DE BENZOTHIAZOLONE AGISSANT COMME AGENTS DE MODULATION DE CANAUX IONIQUES
  申请人：NEUROSEARCH AS

  公开号：WO2000034248A1

  公开（公告）日：2000-06-15

  The present invention relates to ion channel modulating agents. More particularly, the present invention relates to a particular class of chemical compounds that has proven useful as modulators of SKCa, IKCa and BKCa channels. In further aspects, the present invention relates to the use of these SK/IK/BK channel modulating agents for the manufacture of medicaments, and pharmaceutical compositions comprising the SK/IK/BK channel modulating agents. The SK/IK/BK channel modulating agents of the invention are useful for the treatment or alleviation of diseases and conditions associated with the SK/IK/BK channels.

  本发明涉及离子通道调节剂。更具体地，本发明涉及一类已被证明可用作SKCa、IKCa和BKCa通道调节剂的化学化合物。在进一步的方面，本发明涉及使用这些SK/IK/BK通道调节剂制造药物，以及包含SK/IK/BK通道调节剂的制药组合物。本发明的SK/IK/BK通道调节剂可用于治疗或缓解与SK/IK/BK通道相关的疾病和症状。
• Use of intermediate -conductance potassium channels and modulators for diagnosing and treating diseases having disturbed keratinocyte activity
  申请人：——

  公开号：US20040248099A1

  公开（公告）日：2004-12-09

  The invention relates to the use of intermediate-conductance, calcium-activated potassium channels and/or the nucleic acids coding for the same, from humans or mice, for the diagnosis, prevention and/or treatment of illnesses associated with disturbed keratinocyte activity. The invention also relates to the use of the same for identifying pharmacologically active substances. The invention further relates to the use of modulators of intermediate-conductance, calcium-activated potassium channels for the diagnosis, prevention and/or treatment of illnesses associated with disturbed keratinocyte activity.

  本发明涉及使用来自人类或小鼠的中间导电、钙激活钾通道和/或编码其的核酸，用于诊断、预防和/或治疗与干扰角质形成细胞活动相关的疾病。本发明还涉及使用相同的物质来鉴定药理活性物质。本发明进一步涉及使用中间导电、钙激活钾通道的调节剂，用于诊断、预防和/或治疗与干扰角质形成细胞活动相关的疾病。
• Benzoxazoles: Potent Skeletal Muscle Relaxants
  作者：Joseph Sam、James N. Plampin

  DOI：10.1002/jps.2600530518

  日期：1964.5
• NEW BENZIMIDAZOLONE-, BENZOXAZOLONE-, OR BENZOTHIAZOLONE DERIVATIVES AS ION CHANNEL MODULATING AGENTS
  申请人：NEUROSEARCH A/S

  公开号：EP1144387A1

  公开（公告）日：2001-10-17